PatientsVille.com Logo

PatientsVille

Mucosolvan Side Effects

Common Mucosolvan Side Effects


The most commonly reported Mucosolvan side effects (click to view or check a box to report):

Blood Lactate Dehydrogenase Increased (5)
Bronchiectasis (5)
Alanine Aminotransferase Increased (5)
Blood Immunoglobulin G Decreased (5)
Blood Immunoglobulin M Decreased (5)
Aspartate Aminotransferase Increased (5)
Blood Alkaline Phosphatase Increased (5)
Blood Immunoglobulin A Decreased (5)
Pyrexia (4)
Pneumonia (3)
Interstitial Lung Disease (3)
Cardio-respiratory Arrest (3)
Delirium (3)
Bacteria Sputum Identified (2)
Asphyxia (2)
Bronchitis (2)
Hypoglycaemic Unconsciousness (2)
Respiratory Failure (2)
Hyponatraemia (2)
Epilepsy (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Mucosolvan Side Effects Reported to FDA

The following Mucosolvan reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Mucosolvan on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Heart Rate Increased, Chest Discomfort
This is a report of a 48-year-old male patient (weight: NA) from CN, suffering from the following symptoms/conditions: increased upper airway secretion, who was treated with Mucosolvan (dosage: 20 Ml, start time: Nov 24, 2013), combined with:
  • Amoxicillin
and developed a serious reaction and side effect(s). The consumer presented with:
  • Heart Rate Increased
  • Chest Discomfort
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosolvan treatment in male patients, resulting in heart rate increased side effect.

Respiratory Failure, Dyspnoea, Interstitial Lung Disease, Pyrexia
This report suggests a potential Mucosolvan Respiratory Failure, Dyspnoea, Interstitial Lung Disease, Pyrexia side effect(s) that can have serious consequences. A 71-year-old female patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Mucosolvan (dosage: NA) starting Oct 28, 2011. Soon after starting Mucosolvan the patient began experiencing various side effects, including:
  • Respiratory Failure
  • Dyspnoea
  • Interstitial Lung Disease
  • Pyrexia
Drugs used concurrently:
  • Loxoprofen
  • Maglax
  • Omeprazole
  • Zometa
  • Therapeutic Radiopharmaceuticals
  • Antineoplastic Agents
  • Vitamin B12
  • Rebamipide
Although Mucosolvan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as respiratory failure, may still occur.

Left Ventricular Hypertrophy, Heart Valve Incompetence, Arterial Stenosis, Vocal Cord Paralysis, Acute Myocardial Infarction, Chest Pain, Pneumonia, Urinary Tract Infection, Endocarditis
This Left Ventricular Hypertrophy, Heart Valve Incompetence, Arterial Stenosis, Vocal Cord Paralysis, Acute Myocardial Infarction, Chest Pain, Pneumonia, Urinary Tract Infection, Endocarditis problem was reported by a physician from GERMANY. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On May 19, 2011 this consumer started treatment with Mucosolvan (dosage: 75 Mg, Unk). The following drugs were being taken at the same time:
  • Norvasc (10 Mg, Unk)
  • Tacrolimus (10 Mg, Qd)
  • Prednisolone (5 Mg, Qd)
  • Metoprolol (300 Mg, Unk)
  • Aspirin (100 Mg, Unk)
  • Albuterol Sulfate (Unk)
  • Alvocidib (Unk)
  • Aspisol (500 Mg, Unk)
When commencing Mucosolvan, the patient experienced the following unwanted symptoms/side effects:
  • Left Ventricular Hypertrophy
  • Heart Valve Incompetence
  • Arterial Stenosis
  • Vocal Cord Paralysis
  • Acute Myocardial Infarction
  • Chest Pain
  • Pneumonia
  • Urinary Tract Infection
  • Endocarditis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as left ventricular hypertrophy, may become evident only after a product is in use by the general population.

Haemorrhagic Diathesis, Pneumonia, Epilepsy, Disseminated Intravascular Coagulation, Haemorrhage Subcutaneous, Cardiac Failure
This is a report of a 89-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Mucosolvan (ambroxol Hydrochloride) (dosage: NA) starting Dec 29, 2004. Concurrently used drugs:
  • Depakene R (sodium Valproate)
  • Aspirin
  • Pletal (100 Mg, Bid, Oral)
  • Isosorbide Mononitrate
  • Amlodin (amloidpine Besilate)
  • Lisinopril
Soon after that, the consumer experienced the following side effects:
  • Haemorrhagic Diathesis
  • Pneumonia
  • Epilepsy
  • Disseminated Intravascular Coagulation
  • Haemorrhage Subcutaneous
  • Cardiac Failure
The patient was hospitalized and became disabled. This opens a possibility that Mucosolvan (ambroxol Hydrochloride) treatment could cause the above reactions, including haemorrhagic diathesis, and some male subjects may be more susceptible.


Abnormal Behaviour, Delirium
A female patient (weight: NA) from JAPAN with the following symptoms/conditions: bronchitis started Mucosolvan treatment (dosage: 45mg Per Day) on May 14, 2012. Soon after starting Mucosolvan treatment, the subject experienced various side effects, including:
  • Abnormal Behaviour
  • Delirium
Concurrently used drugs:
  • Clarithromycin (400mg Per Day)
  • Acetaminophen (1500mg Per Day)
  • Relenza (4iuax Per Day)
This finding indicates that some female patients could be more vulnerable to Mucosolvan.

Product Quality Issue
A 1-year-old male patient from KENYA (weight: NA) experienced symptoms, such as: upper respiratory tract infection,pyrexia and was treated with Mucosolvan(dosage: 15ml Per Day). The treatment was initiated on Jan 14, 2012. After that a consumer reported the following side effect(s):
  • Product Quality Issue
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Mucosolvan efficacy:
  • Acetaminophen (10ml Per Day)
  • Cefuroxime (125mg Per Day)


Ventricular Fibrillation, Electrocardiogram Qt Prolonged, Ventricular Tachycardia, Cardio-respiratory Arrest
In this report, Mucosolvan was administered for the following condition: NA.A 46-year-old female consumer from JAPAN (weight: NA) started Mucosolvan treatment (dosage: 45 Mg, 1x/day) on Jan 05, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Ventricular Fibrillation
  • Electrocardiogram Qt Prolonged
  • Ventricular Tachycardia
  • Cardio-respiratory Arrest
A possible interaction with other drugs could have contributed to this reaction:
  • Zithromax (500 Mg, 1x/day)
  • Asverin (60 Mg, 1x/day)
  • Bakumondouto (27 G, 1x/day)
  • Zithromax
  • Depas (0.5 Mg, 1x/day)
The patient was hospitalized and became disabled.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Mucosolvan treatment could be related to the listed above side effect(s).

Wheezing, Pyrexia, Platelet Count Decreased
This is a report of the following Mucosolvan side effect(s):
  • Wheezing
  • Pyrexia
  • Platelet Count Decreased
A male patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Mucosolvan (dosage: Unk) starting: Dec 15, 2002.The following concurrently used drugs could have generated interactions:
  • Depas (Unk)
  • Theophylline (Unk)
  • Risedronate Sodium (Unk)
  • Omeprazole (Unk)
  • Spelear (Unk)
  • Aspara-ca (Unk)
  • Symbicort (Unk)
  • Montelukast Sodium (Unk)
The patient was hospitalized.This report suggests that a Mucosolvan treatment could be associated with the listed above side effect(s).

Aortic Dissection, Arrhythmia
This Mucosolvan report was submitted by a 78-year-old female consumer from JAPAN (weight: NA). The patient was diagnosed with: NA and Mucosolvan was administered (dosage: NA) starting: Nov 15, 2011. The consumer developed a set of symptoms:
  • Aortic Dissection
  • Arrhythmia
Other drugs used simultaneously:
  • Budesonide W/formoterol Fumarate
  • Alfarol
  • Rabeprazole Sodium
The patient was hospitalized.Those unexpected symptoms could be linked to a Mucosolvan treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Loss Of Consciousness
This is a report of a possible correlation between Mucosolvan use and the following symptoms/side effect(s):
  • Loss Of Consciousness
which could contribute to an assessment of Mucosolvan risk profile.A 76-year-old male consumer from JAPAN (weight: NA) was suffering from NA and was treated with Mucosolvan (dosage: Unk) starting Jan 01, 1985.Other concurrent medications:
  • Marzulene Es /00518301/ (Unk)
  • Epinastine Hydrochloride (Unk)
  • Losartan Potassium (Unk)
  • Marzulene Es
  • Theo-dur (Unk)
  • Losartan Potassium (Unk)
  • Prednisolone (Unk)
  • Epinastine Hydrochloride (Unk)


Pyrexia, Musculoskeletal Stiffness
A 20-year-old male patient from JAPAN (weight: NA) presented with the following symptoms: NA and after a treatment with Mucosolvan (dosage: NA) experienced the following side effect(s):
  • Pyrexia
  • Musculoskeletal Stiffness
The treatment was started on NS. Mucosolvan was used in combination with the following drugs:
  • Zonisamide
  • Zonisamide
  • Epirenat
  • Keppra
  • Bisolvon
  • Baclofen
This report could alert potential Mucosolvan consumers.

Chronic Obstructive Pulmonary Disease, Pneumonia
In this report, a male patient from JAPAN (weight: NA) was affected by a possible Mucosolvan side effect.The patient was diagnosed with emphysema. After a treatment with Mucosolvan (dosage: 45 Mg, start date: Nov 20, 2010), the patient experienced the following side effect(s):
  • Chronic Obstructive Pulmonary Disease
  • Pneumonia
The following simultaneously used drugs could have led to this reaction:
  • Spiriva (5 Mcg)
  • Bisolvon (12 Mg)
  • Levothyroxine Sodium (50 Mcg)
  • Garenoxacin Mesylate (200 Mg)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Mucosolvan treatment.

Hypoglycaemic Unconsciousness, Hypoxic-ischaemic Encephalopathy, Cardio-respiratory Arrest
This is a report of a 81-year-old male patient from JAPAN (weight: NA), who used Mucosolvan (dosage: NA) for a treatment of emphysema. After starting a treatment on Oct 15, 2010, the patient experienced the following side effect(s):
  • Hypoglycaemic Unconsciousness
  • Hypoxic-ischaemic Encephalopathy
  • Cardio-respiratory Arrest
The following drugs could possibly have interacted with the Mucosolvan treatment
  • Methy F
  • Diazoxide
  • Lansoprazole
  • Tamsulosin Hydrochloride
  • Pioglitazone Hydrochloride
  • Amaryl
  • Nipolazin
  • Ferrous Citrate
The patient was hospitalized.Taken together, these observations suggest that a Mucosolvan treatment could be related to side effect(s), such as Hypoglycaemic Unconsciousness, Hypoxic-ischaemic Encephalopathy, Cardio-respiratory Arrest.

Decreased Appetite, Gait Disturbance, Muscular Weakness, Dyskinesia
This decreased appetite side effect was reported by a physician from JAPAN. A 79-year-old male patient (weight:NA) experienced the following symptoms/conditions: bronchitis chronic,gastrooesophageal reflux disease,hypertension,lumbar spinal stenosis. The patient was prescribed Mucosolvan (dosage: 15 Mg, 3x/day), which was started on Oct 23, 2010. Concurrently used drugs:
  • Omeprazole (10 Mg, 1x/day)
  • Valsartan (80 Mg, 1x/day)
  • Lyrica (75 Mg, 2x/day)
  • Lyrica (75 Mg, 1x/day)
  • Opalmon (5 Ug, 3x/day)
  • Methycobal
  • Pletal (100 Mg, 2x/day)
  • Neurotropin (8 Units Twice Daily)
When starting to take Mucosolvan the consumer reported the following symptoms:
  • Decreased Appetite
  • Gait Disturbance
  • Muscular Weakness
  • Dyskinesia
The patient was hospitalized. These side effects may potentially be related to Mucosolvan.

Pneumocystis Jiroveci Pneumonia
This is a Mucosolvan side effect report of a 55-year-old male patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Mucosolvan (dosage:Unk, start time: Apr 23, 2005), combined with:
  • Amaryl (Unk)
  • Lafutidine (Unk)
  • Enbrel (25 Mg, 2x/week)
  • Methycobal (Unk)
  • Enbrel (25 Mg, Weekly)
  • Rimatil (200 Mg, 1x/day)
  • Aspirin (Unk)
  • Rinderon /00008501/ (1.5 Mg, 1x/day)
, and developed a serious reaction and a pneumocystis jiroveci pneumonia side effect. The patient presented with:
  • Pneumocystis Jiroveci Pneumonia
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Mucosolvan treatment in male patients suffering from NA, resulting in pneumocystis jiroveci pneumonia.


This report suggests a potential Mucosolvan sudden death side effect(s) that can have serious consequences. A 91-year-old male patient from GERMANY (weight:NA) was diagnosed with the following health condition(s): NA and used Mucosolvan (dosage: NA) starting Aug 24, 2011. Soon after starting Mucosolvan the patient began experiencing various side effects, including:
    Drugs used concurrently:
    • Ceftriaxon (1 Df, Unk)
    • Ramipril
    • Tramal Long
    • Enoxaparin Sodium
    • Avelox (Unk)
    • Torsemide
    Although Mucosolvan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as sudden death, may still occur.

    Hypoglycaemic Unconsciousness, Cardio-respiratory Arrest
    This hypoglycaemic unconsciousness problem was reported by a physician from JAPAN. A 81-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): emphysema.On Jul 23, 2008 a consumer started treatment with Mucosolvan (dosage: NA). The following drugs/medications were being taken at the same time:
    • Ferrous Citrate
    • Glycoran
    • Pioglitazone Hydrochloride
    • Lansoprazole
    • Tamsulosin Hydrochloride
    • Nipolazin
    • Amaryl
    • Methy F
    When commencing Mucosolvan, the patient experienced the following unwanted symptoms /side effects:
    • Hypoglycaemic Unconsciousness
    • Cardio-respiratory Arrest
    The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as hypoglycaemic unconsciousness, may become evident only after a product is in use by the general population.

    Hyponatraemia
    This is a Mucosolvan side effect report of a 65-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Mucosolvan (dosage: Unk) starting NS. Concurrently used drugs:
    • Sennoside (Unk)
    • Epinastine Hydrochloride (Unk)
    • Coniel (Unk)
    • Halomonth
    • Depas (Unk)
    • Cerekinon (Unk)
    • Zyprexa (15 Mg, Qd)
    Soon after that, the consumer experienced the following of symptoms:
    • Hyponatraemia
    The patient was hospitalized. This opens a possibility that Mucosolvan could cause hyponatraemia and that some male patients may be more susceptible.

    Anaphylactic Reaction, Asphyxia
    A male patient (weight: NA) from CHINA with the following symptoms: postoperative care started Mucosolvan treatment (dosage: 15 Mg) on May 18, 2011. Soon after starting Mucosolvan treatment, the consumer experienced several side effects, including:
    • Anaphylactic Reaction
    • Asphyxia
    . Concurrently used drugs:
    • Atrovent (500 Mcg)
    This finding indicates that some patients can be more vulnerable to developing Mucosolvan side effects, such as anaphylactic reaction.

    Interstitial Lung Disease
    This interstitial lung disease side effect was reported by a physician from JAPAN. A 72-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Mucosolvan (dosage: NA), which was started on Jun 11, 2011. Concurrently used drugs:
    • Mucosta
    • Pursennid
    • Ulcerlmin
    • Amlodipine
    • Maalox
    • Paxil (20mg Per Day)
    • Clarithromycin
    • Zyloric 100 (100mg Per Day)
    .When starting to take Mucosolvan the consumer reported symptoms, such as:
    • Interstitial Lung Disease
    These side effects may potentially be related to Mucosolvan. The patient was hospitalized.

    Apathy, Disturbance In Attention, Depression
    This is a report of a 68-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: bronchitis,nicotine dependence, who was treated with Mucosolvan (dosage: 45mg Per Day, start time: Jun 06, 2011), combined with:
    • Varenicline Tartrate (0.5 Mg, 2x/day)
    • Varenicline Tartrate (0.5 Mg, 1x/day)
    • Varenicline Tartrate (1.0 Mg, 2x/day)
    • Sekinarin (2mg, Unk)
    and developed a serious reaction and side effect(s). The consumer presented with:
    • Apathy
    • Disturbance In Attention
    • Depression
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosolvan treatment in female patients, resulting in apathy side effect.

    Hyponatraemia
    This report suggests a potential Mucosolvan Hyponatraemia side effect(s) that can have serious consequences. A 65-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Mucosolvan (dosage: Unk) starting NS. Soon after starting Mucosolvan the patient began experiencing various side effects, including:
    • Hyponatraemia
    Drugs used concurrently:
    • Coniel (Unk)
    • Alesion (Unk)
    • Depas (Unk)
    • Sennoside (Unk)
    • Cerekinon (Unk)
    • Zyprexa (15 Mg, Qd)
    The patient was hospitalized. Although Mucosolvan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hyponatraemia, may still occur.

    Anaphylactic Reaction, Asphyxia
    This Anaphylactic Reaction, Asphyxia problem was reported by a physician from CHINA. A 67-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: postoperative care. On May 18, 2011 this consumer started treatment with Mucosolvan (dosage: 15 Mg). The following drugs were being taken at the same time:
    • Atrovent (500 Mcg)
    When commencing Mucosolvan, the patient experienced the following unwanted symptoms/side effects:
    • Anaphylactic Reaction
    • Asphyxia
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as anaphylactic reaction, may become evident only after a product is in use by the general population.

    Hepatic Function Abnormal, Blood Phosphorus Increased, Insomnia
    This is a report of a 80-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Mucosolvan (dosage: Daily Dose 45 Mg) starting Jan 24, 2011. Concurrently used drugs:
    • Urso 250 (Daily Dose 600 Mg)
    • Nexavar (600 Mg/day)
    • Alinamin F [fursultiamine] (Daily Dose 75 Mg)
    • Nexavar (200 Mg, Tid)
    • Nexavar (400 Mg/day)
    • Livact (Daily Dose 12.45 Mg)
    • Keratinamin (Unk)
    Soon after that, the consumer experienced the following side effects:
    • Hepatic Function Abnormal
    • Blood Phosphorus Increased
    • Insomnia
    This opens a possibility that Mucosolvan treatment could cause the above reactions, including hepatic function abnormal, and some male subjects may be more susceptible.

    Epilepsy
    A 62-year-old female patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Mucosolvan treatment (dosage: NA) on May 30, 2011. Soon after starting Mucosolvan treatment, the subject experienced various side effects, including:
    • Epilepsy
    Concurrently used drugs:
    • Tegretol
    • Bisolvon (Unk)
    This finding indicates that some female patients could be more vulnerable to Mucosolvan.

    1 of 2 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Mucosolvan Side Effects

    Did You Have a Mucosolvan Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Mucosolvan for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Mucosolvan Safety Alerts, Active Ingredients, Usage Information

    More About Mucosolvan

    Side Effects reported to FDA: 40

    Mucosolvan safety alerts: No

    Reported deaths: 7

    Reported hospitalizations: 19

    Latest Mucosolvan clinical trials